Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost

Overview of attention for article published in Nature Communications, January 2025

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

bluesky: 3 Bluesky users

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 3 Bluesky posts from 3 Bluesky users, with an upper bound of 3,889 followers.

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost www.nature.com/articles/s41...

RP @atranscendedman.bsky.social: In a US trial of 985 people, higher antibody levels after a second COVID booster cut Omicron risk, especially in those with prior infection. Naïve individuals showed weaker protection, highlighting the impact of immune h…

In a US trial of 985 people, higher antibody levels after a second COVID booster cut Omicron risk, especially in those with prior infection. Naïve individuals showed weaker protection, highlighting the impact of immune history. www.nature.com/articles/…

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.